BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17381528)

  • 1. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?
    Perseghin P; Galimberti S; Balduzzi A; Bonanomi S; Baldini V; Rovelli A; Dassi M; Rambaldi A; Castagna L; Corti P; Pogliani EM; Uderzo C
    Ther Apher Dial; 2007 Apr; 11(2):85-93. PubMed ID: 17381528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
    J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
    Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
    Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
    Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
    Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive extracorporeal photochemotherapy in pediatric patients with chronic graft-versus-host disease (cGVHD).
    Duzovali O; Chan KW
    Pediatr Blood Cancer; 2007 Feb; 48(2):218-21. PubMed ID: 16628538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease.
    Di Renzo M; Rubegni P; Pasqui AL; Pompella G; De Aloe G; Sbano P; Cuccia A; Castagnini C; Auteri A; Laghi Pasini F; Fimiani M
    Br J Dermatol; 2005 Jul; 153(1):59-65. PubMed ID: 16029327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
    Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
    Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures.
    Perotti C; Torretta L; Viarengo G; Roveda L; Bernuzzi S; Carbone S; Del Fante C; La Torre R; Locatelli F; Bonetti F; Gabba P; Bellosta M; Salvaneschi L
    Haematologica; 1999 Mar; 84(3):237-41. PubMed ID: 10189389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
    Perotti C; Del Fante C; Tinelli C; Viarengo G; Scudeller L; Zecca M; Locatelli F; Salvaneschi L
    Transfusion; 2010 Jun; 50(6):1359-69. PubMed ID: 20113452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
    Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology.
    Tsirigotis P; Kaloyannidis P; Papalexandri A; Baltadakis I; Karakasis D; Batsis I; Sakellari I; Kitra V; Goussetis E; Papageorgiou S; Spyridonidis A; Graphakos S; Harhalakis N; Dervenoulas I; Anagnostopoulos A
    Transfus Apher Sci; 2012 Apr; 46(2):173-80. PubMed ID: 22036202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E; Palangio M; Gonzalez J; Adler KR; Rowley SD; Goldberg SL
    Bone Marrow Transplant; 2003 Feb; 31(4):291-4. PubMed ID: 12621465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.
    Del Fante C; Scudeller L; Viarengo G; Bernasconi P; Perotti C
    Transfusion; 2012 Sep; 52(9):2007-15. PubMed ID: 22320219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure.
    Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M
    J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses.
    Garban F; Drillat P; Makowski C; Jacob MC; Richard MJ; Favrot M; Sotto JJ; Bensa JC; Cahn JY
    Haematologica; 2005 Aug; 90(8):1096-101. PubMed ID: 16079109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.